Table of Contents Table of Contents
Previous Page  201 / 1096 Next Page
Information
Show Menu
Previous Page 201 / 1096 Next Page
Page Background

S188

ESTRO 36

_______________________________________________________________________________________________

plans needs to be built to achieve the full potential of

ART.

OC-0354 Dosimetric impact of anatomical changes in

photon and particle therapy for pancreatic cancer

K. Crama

1

, A.C. Houweling

1

, J. Visser

1

, K. Fukata

2

, C.R.N.

Rasch

1

, T. Ohno

2

, A. Bel

1

, A. Van der Horst

1

1

Academic Medical Center, Department of Radiation

Oncology, Amsterdam, The Netherlands

2

Gunma University, Gunma University Heavy Ion Medical

Center, Maebashi, Japan

Purpose or Objective

Radiotherapy of pancreatic tumors is toxic due to the high

dose to surrounding organs-at-risk (OARs). Irradiation with

charged particles is characterized by a sharp dose fall-off

around the target area. Compared to photon therapy,

OARs can be further spared while delivering a high dose to

the tumor. Treatment planning studies in pancreatic

cancer patients have shown this benefit of charged

particle

therapy

over

photon

therapy.

However, intra- and interfractional changes may greatly

affect the robustness of particle therapy. Past studies only

investigated differences in planned dose; studies

comparing the robustness of different modalities have not

been published yet.

We compared the dosimetric impact of interfractional

anatomical changes (i.e. body contour differences,

gastrointestinal gas volume changes and setup errors) in

photon, proton and carbon ion therapy for pancreatic

cancer patients. Intrafractional changes were not taken

into account in this study.

Material and Methods

Photon, proton and carbon ion treatment plans (36 Gy, 12

fractions) were created for 9 patients. For the particle

therapy plans, the relative radiobiological effectiveness

was taken into account. To simulate daily online setup

correction, the CBCTs were rigidly registered (only

translations) to the planning CT using fiducial markers.

Fraction dose calculation was then made possible by

deformable registering the planning CT to each of the 12

CBCTs. Gastrointestinal gas was delineated on each CBCT

and copied to the deformed CT, a relative density override

was

applied

for

dose

calculation

(0.01).

Fraction doses were accumulated rigidly. To compare

planned and accumulated dose, for each radiotherapy

modality, dose volume histogram (DVH) parameters of the

planned and accumulated dose were determined for the

internal gross tumor volume (iGTV), internal clinical

target volume (iCTV) and OARS (duodenum, stomach,

kidneys, liver and spinal cord).

Results

Photon plans were highly robust against interfractional

anatomical changes. The difference between planned and

accumulated DVH parameters for the photon plans was

≤0.5% for the target and OARs. For proton therapy,

coverage of the iCTV was considerably reduced for the

accumulated compared to the planned dose: the mean

near-minimum dose (D98%) of the iCTV reduced from

98.1% to 90.3% [79.4%–95.3%](Figure). For carbon ion

therapy it was even worse; D98%

was reduced with 10%,

from 98.6% to 88.6% [80.7%–92.7%]. The DVH parameters

of the OARs differed ≤3% between both particle

modalities. For all modalities the near-maximum dose

(D2%) did not differ.

Conclusion

Photon therapy is highly robust against interfractional

anatomical changes and setup errors in pancreatic cancer

patients. However, in particle therapy with either protons

or carbon ions, severe reductions in target dose coverage

were observed. Implementation of particle therapy for

pancreaticcancer patients should be done with great care

and interfractional anatomical changes must be accounted

for.

OC-0355 Which anatomical changes in Head&Neck

cancer lead to Repeat CT/planning?

S. Van Beek

1

, O. Hamming-Vrieze

1

, A. Al Mamgani

1

, A.

Navran

1

, J. Van de Kamer

1

, P. Remeijer

1

1

The Netherlands Cancer Institute, Department of

Radiation Oncology, Amsterdam, The Netherlands

Purpose or Objective